Significant Social Security Changes Take Effect Today, Sept. 30, Thanks to President Donald Trump
Changes to Social Security Benefits Under Executive Order Social Security undergoes adjustments about every year. Recently, an executive order from President Trump has directly affected how over 390,800 beneficiaries receive their monthly payments. Moreover, it’s worth noting that it will be a few weeks before the Social Security Administration (SSA) discloses several changes scheduled for […]
S&P 500 Today: Robinhood and Western Digital Rise; Vistra Shares Decline
Key Takeout The online brokerage began trading on September 19, 2025, but utility stocks dropped following a significant contract announcement. Shares of Robinhood surged after CEO Vlad Tenev showcased growth in the platform’s event contract trading business. Vistra’s stock took a dive after the announcement of a contract related to the Comanche Peak nuclear power […]
Reasons for the Increase in AppLovin Stock Today
Morgan Stanley has increased its price target for Applovin to $750, reaffirming its overweight rating. The bank noted the soft launch of the Axon ADS Manager set for October 1. This follows a series of optimistic predictions from analysts regarding Axon’s potential beyond gaming. Applovin stocks experienced a rise on Monday, buoyed by Morgan Stanley’s […]
Trump meets with congressional leaders today as a government shutdown approaches
Potential Government Shutdown Looms as Trump Meets Congressional Leaders President Donald Trump is scheduled to meet with top Congressional leaders at 2 PM on Monday, just ahead of a looming government shutdown set to begin at 12:01 AM on Wednesday. Despite this critical meeting, there’s a noticeable lack of optimism surrounding the discussions. Senate minority […]
The reality is whatever Hillary claims today
Contradictions in Progressive Politics If you’re involved in politics, it’s clear that progressives often present conflicting views. This inconsistency tends to keep conservative commentators quite occupied. Initially, young conservatives might relish pointing out these contradictions. However, there’s an important lesson here: only those who are honest truly change their minds when they encounter inconsistencies in […]
The Best Growth Stock to Purchase for $1,000 Today
The Dutch Brothers have been increasing their presence steadily over the years. If you’re on the lookout for promising growth stocks beyond the AI sector, Dutch Brothers should definitely be high on your list. Their significant success as a restaurant chain is driven by a proactive yet strategic approach to store expansion. This strategy mirrors […]
The Best Dividend Stocks to Invest in With $10,000 Today
These four stocks can deliver solid returns in a diverse investment portfolio. I’ve always had a thing for dividend stocks. There’s something satisfying about receiving those monthly notices—well, for some stocks—indicating that my dividends have been applied and reinvested. Plus, getting news about increased yields from companies I’ve invested in feels rewarding. It’s like a […]
S&P 500 Today: Electronic Arts Stock Rises on Buyout Discussions; Costco Dips
Key takeout On Friday, September 26, 2025, shares of a video game company surged after big box retailers faced challenges with their revenue reports, coinciding with news of potential acquisitions. Electronic Arts saw its stocks rise following rumors about possible bids to turn the video game maker private. Costco’s reported growth in U.S. store sales […]
Reasons for the Decline in BigBear.ai Stock Today
Bigbear recently expressed confidence in winning a naval contract earlier this week. This announcement helped boost BigBear’s stock to its highest point in several months. That said, the real issue lies in the company’s revenue growth, which is what investors should be paying attention to, rather than just the publicity. As of 1:55 PM ET, […]
Why Has PepGen Stock (PEPG) Increased by 125% Today?
PEPGEN Stock Rises After Positive Trial Results PEPGEN (PEPG) saw a significant boost in its stock value on Thursday, following the release of results from a Phase 1 clinical trial. This research focused on PGN-EDODM1 as a potential treatment for myotonic dystrophy type 1, which is a genetic muscle disorder leading to progressive weakness and […]